Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial
Hemasphere. 2020 Aug 12;4(4):e370.
doi: 10.1097/HS9.0000000000000370.
eCollection 2020 Aug.
1 Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
2 Department of Hematology, Amsterdam UMC, The Netherlands.
3 HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
4 Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
5 Department of Hematology, Isala Clinics, Zwolle, The Netherlands.
6 Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands.
7 Department of Hematology, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.
8 Myeloma Unit, Division of Hematology, Azienda Ospedaliero Universitaria Citta della Salute e della Scienza di Torino, University of Turin, Turin, Italy.